Zarei Hamed, Azimi Amir, Ansarian Arash, Raad Arian, Tabatabaei Hossein, Roshdi Dizaji Shayan, Saadatipour Narges, Dadras Ayda, Ataei Neamatollah, Hosseini Mostafa, Yousefifard Mahmoud
Physiology Research Center, Iran University of Medical Sciences, Hemmat Highway, P.O Box: 14665-354, Tehran, Iran.
Pediatric Chronic Kidney Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
BMC Nephrol. 2025 Mar 5;26(1):117. doi: 10.1186/s12882-025-04033-2.
Acute kidney injury (AKI) is a significant health concern in hospitalized children and is associated with increased mortality. However, the true burden of AKI-associated mortality in pediatric populations remains unclear.
To determine the pooled incidence of mortality independently associated with AKI in hospitalized children globally.
Medline and Embase were searched for studies published by March 2024.
The inclusion criteria encompassed observational studies involving hospitalized pediatric patients (< 18 years old) with AKI. Only studies that identified AKI as an independent risk factor for increased mortality in multivariate analysis were considered.
Studies with at least 100 AKI patients were included in the meta-analysis. Two authors extracted data on the study and patients' characteristics and mortality across AKI stages and assessed the risk of bias. We used a random-effects meta-analysis to generate pooled estimates of mortality.
Analysis of 60 studies including 133,876 children with AKI revealed a pooled in-hospital mortality rate of 18.27% (95% CI: 14.89, 21.65). Mortality increased with AKI severity; 8.19% in stage 1, 13.44% in stage 2, and 27.78% in stage 3. Subgroup analyses showed no significant differences across geographical regions, income levels, or AKI definition criteria. The pooled post-discharge mortality rate was 6.84% (95% CI: 5.86, 7.82) in a 1-9-year follow-up period.
This meta-analysis demonstrates a substantial global burden of AKI-associated mortality in hospitalized children, with higher mortality rates in more severe AKI stages. These findings highlight the critical need for early detection and intervention strategies in pediatric AKI management.
Not applicable.
急性肾损伤(AKI)是住院儿童的一个重大健康问题,且与死亡率增加相关。然而,儿科人群中与AKI相关的死亡率的真实负担仍不明确。
确定全球住院儿童中与AKI独立相关的死亡率的合并发生率。
检索了Medline和Embase截至2024年3月发表的研究。
纳入标准包括涉及住院的急性肾损伤儿科患者(<18岁)的观察性研究。仅考虑在多变量分析中将AKI确定为死亡率增加的独立危险因素的研究。
至少有100例AKI患者的研究纳入荟萃分析。两位作者提取了关于研究、患者特征以及AKI各阶段死亡率的数据,并评估了偏倚风险。我们使用随机效应荟萃分析来生成死亡率的合并估计值。
对60项研究(包括133876例AKI儿童)的分析显示,合并住院死亡率为18.27%(95%CI:14.89,21.65)。死亡率随AKI严重程度增加;1期为8.19%,2期为13.44%,3期为27.78%。亚组分析显示,不同地理区域、收入水平或AKI定义标准之间无显著差异。在1至9年的随访期内,合并出院后死亡率为6.84%(95%CI:5.86,7.82)。
这项荟萃分析表明,住院儿童中与AKI相关的死亡率在全球范围内负担沉重,在更严重的AKI阶段死亡率更高。这些发现凸显了在儿科AKI管理中早期检测和干预策略的迫切需求。
不适用。